Skip to main content

Published locations for URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trial

User login

  • Reset your password
  • /content/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2-gout-trial
  • /clinicianreviews/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2
  • /familypracticenews/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2
  • /fedprac/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2-gout-trial
  • /internalmedicinenews/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase
  • /rheumatologynews/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2
  • /rheumatology/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2-gout
  • /internalmedicine/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2
  • /familymedicine/article/263355/gout/urat1-inhibitor-shows-substantial-uric-acid-reduction-phase-2